First National Bank of Omaha’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $331K | Sell |
9,158
-904
| -9% | -$32.7K | 0.02% | 283 |
|
|
2024
Q3 | $314K | Sell |
10,062
-352
| -3% | -$11K | 0.02% | 283 |
|
|
2024
Q2 | $279K | Buy |
10,414
+1,222
| +13% | +$32.7K | 0.02% | 288 |
|
|
2024
Q1 | $301K | Sell |
9,192
-3,473
| -27% | -$114K | 0.02% | 286 |
|
|
2023
Q4 | $367K | Sell |
12,665
-1,517
| -11% | -$43.9K | 0.02% | 284 |
|
|
2023
Q3 | $391K | Sell |
14,182
-264
| -2% | -$7.28K | 0.03% | 281 |
|
|
2023
Q2 | $434K | Hold |
14,446
| – | – | 0.02% | 276 |
|
|
2023
Q1 | $523K | Sell |
14,446
-580
| -4% | -$21K | 0.03% | 259 |
|
|
2022
Q4 | $536K | Sell |
15,026
-1,370
| -8% | -$48.9K | 0.03% | 264 |
|
|
2022
Q3 | $555K | Sell |
16,396
-637
| -4% | -$21.6K | 0.04% | 255 |
|
|
2022
Q2 | $493K | Buy |
17,033
+662
| +4% | +$19.2K | 0.03% | 270 |
|
|
2022
Q1 | $529K | Sell |
16,371
-5,805
| -26% | -$188K | 0.03% | 269 |
|
|
2021
Q4 | $647K | Sell |
22,176
-1,778
| -7% | -$51.9K | 0.03% | 265 |
|
|
2021
Q3 | $639K | Buy |
23,954
+851
| +4% | +$22.7K | 0.03% | 264 |
|
|
2021
Q2 | $605K | Hold |
23,103
| – | – | 0.03% | 269 |
|
|
2021
Q1 | $605K | Buy |
+23,103
| New | +$605K | 0.03% | 269 |
|